Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 90 | 30 | 45 | 45 | 45 |
| Gross Profit | 90 | 30 | 45 | 45 | 45 |
| Operating Expenses | 3,495 | 4,151 | 4,676 | 3,453 | 4,021 |
| Operating Income | -3,405 | -4,121 | -4,631 | -3,408 | -3,976 |
| Other Income | -6 | 11 | 646 | 14 | 9 |
| Pre-tax Income | -3,411 | -4,110 | -3,985 | -3,395 | -3,968 |
| Net Income Continuous | -3,411 | -4,110 | -3,628 | -3,395 | -3,968 |
| Net Income | $-3,411 | $-4,110 | $-3,628 | $-3,395 | $-3,968 |
| EPS Basic Total Ops | -2.00 | -2.50 | -1.50 | -2.00 | -2.00 |
| EPS Basic Continuous Ops | -1.81 | -2.20 | -1.90 | -1.84 | -2.17 |
| EPS Diluted Total Ops | -2.00 | -2.50 | -1.50 | -2.00 | -2.00 |
| EPS Diluted Continuous Ops | -1.81 | -2.20 | -1.90 | -1.84 | -2.17 |
| EBITDA(a) | $-3,352 | $-4,074 | $-4,586 | $-3,377 | $-3,964 |